Ondine Biomedical (OBI) Stock Chart & Stock Price History C$13.00 +0.42 (+3.30%) As of 08/4/2025 05:01 PM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsHeadlinesBuy This Stock Ondine Biomedical Stock Price Performance The Ondine Biomedical (OBI) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 67.74%, with a year-to-date return of 36.84%. In the past month, the stock has decreased 8.77%, reflecting recent market activity. As of the latest close, Ondine Biomedical traded at C$13.00 with a market cap of C$93.47 million and volume of 11,146 shares. Receive OBI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Ondine Biomedical and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-1.89%1 Month Performance-8.77%3 Month Performance+43.01%Year-To-Date Performance+36.84%1 Year Performance+67.74% OBI Stock Chart for Tuesday, August, 5, 2025 OBI Chart by TradingView Ondine Biomedical Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/04/2025C$12.59C$13.00+3.30%C$13.39C$12.5011,146 shsC$93.47 million08/01/2025C$13.25C$12.59-5.02%C$13.50C$12.59106,277 shsC$90.49 million07/31/2025C$13.25C$13.25C$13.50C$13.10196,070 shsC$95.27 million07/30/2025C$13.25C$13.25C$13.66C$13.18128,679 shsC$95.27 million07/29/2025C$12.75C$13.25+3.92%C$13.47C$12.501.71 million shsC$95.27 million07/28/2025C$13.28C$12.75-3.99%C$13.50C$12.61321,146 shsC$91.67 million07/25/2025C$13.50C$13.28-1.63%C$13.38C$13.10336,727 shsC$95.48 million07/24/2025C$13.25C$13.50+1.89%C$13.50C$13.30648,675 shsC$97.07 million07/23/2025C$13.25C$13.25C$13.50C$13.0042,550 shsC$95.27 million07/22/2025C$13.25C$13.25C$13.50C$13.0038,619 shsC$95.27 million Get the Latest News and Ratings for OBI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Ondine Biomedical and its competitors with MarketBeat's FREE daily newsletter. 07/21/2025C$12.70C$13.25+4.33%C$13.50C$13.10301,111 shsC$95.27 million07/18/2025C$13.75C$12.70-7.64%C$13.88C$12.69339,935 shsC$91.31 million07/17/2025C$14.50C$13.75-5.17%C$14.56C$13.50475,628 shsC$98.86 million07/16/2025C$14.50C$14.50C$14.50C$14.0010,041 shsC$104.26 million07/15/2025C$14.50C$14.50C$15.00C$14.5037,364 shsC$104.26 million07/14/2025C$14.00C$14.50+3.57%C$15.00C$13.50620,442 shsC$104.26 million07/11/2025C$13.75C$14.00+1.82%C$14.00C$13.50105,158 shsC$100.66 million07/10/2025C$13.75C$13.75C$13.75C$13.7115,990 shsC$98.86 million07/09/2025C$13.75C$13.75C$14.00C$13.5053,203 shsC$98.86 million07/08/2025C$13.75C$13.75C$14.00C$13.50145,004 shsC$98.86 million07/07/2025C$14.06C$13.75-2.20%C$14.30C$13.65283,512 shsC$98.86 million07/04/2025C$14.25C$14.06-1.33%C$14.75C$14.06172,762 shsC$101.09 million Related Companies Faron Pharmaceuticals Oy Stock Chart Bioventix Stock Chart Avacta Group Stock Chart 4basebio Stock Chart Scancell Stock Chart hVIVO Stock Chart Futura Medical Stock Chart SkinBioTherapeutics Stock Chart Tissue Regenix Group Stock Chart Sareum Stock Chart Receive OBI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Ondine Biomedical and its competitors with MarketBeat's FREE daily newsletter. This page (LON:OBI) was last updated on 8/5/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | SponsoredLeaked Gov’t Memo Reveals $100 Trillion DeadlineOnly Days Left to Claim Your Share of Trump's $100T Play Trump's economic blueprint is about to go live, an...Stansberry Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ondine Biomedical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ondine Biomedical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
